Extending the scope of neuropeptidomics in the mammalian brain

EuPA Open Proteomics

Volumn 3, Issue , 2014, Pages 273-279

  Zhang, Xiaozhe ^a   Petruzziello, Filomena ^b   Rainer, Gregor ^b  

^a DALIAN INSTITUTE OF CHEMICAL PHYSICS   (China)

^b UNIVERSITY OF FRIBOURG   (Switzerland)

Author keywords

Brain; Mass spectrometry; Neuropeptides; Tree shrews

Indexed keywords

NEUROPEPTIDE;

ARTICLE; BRAIN; CENTRAL NERVOUS SYSTEM DISEASE; COLLISIONALLY ACTIVATED DISSOCIATION; DRUG RESPONSE; HUMAN; INTERMETHOD COMPARISON; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; NEUROCHEMISTRY; NEUROPEPTIDOMICS; NONHUMAN; PEPTIDE ANALYSIS; PEPTIDOMICS; PRIORITY JOURNAL; PROTEIN DEGRADATION; TISSUE PREPARATION;

EID: 84902482481     PISSN: None     EISSN: 22129685     Source Type: Journal    
DOI: 10.1016/j.euprot.2014.04.004     Document Type: Article

References (51)

1. Hokfelt T., Broberger C., Xu Z.Q., Sergeyev V., Ubink R., Diez M. Neuropeptides - an overview. Neuropharmacology 2000, 39(8):1337-1356.
2. Nilsson A., Falth M., Zhang X., Kultima K., Skold K., Svenningsson P., et al. Striatal alterations of secretogranin-1, somatostatin, prodynorphin, and cholecystokinin peptides in an experimental mouse model of Parkinson disease. Mol Cell Proteomics 2009, 8(5):1094-1104.
3. Brockmann A., Annangudi S.P., Richmond T.A., Ament S.A., Xie F., Southey B.R., et al. Quantitative peptidomics reveal brain peptide signatures of behavior. Proc Natl Acad Sci U S A 2009, 106(7):2383-2388.
4. Svensson M., Skold K., Svenningsson P., Andren P.E. Peptidomics-based discovery of novel neuropeptides. J Proteome Res 2003, 2(2):213-219.
5. Rubakhin S.S., Romanova E.V., Nemes P., Sweedler J.V. Profiling metabolites and peptides in single cells. Nat Methods 2011, 8(Suppl. 4):S20-S29.
6. Fricker L.D., Lim J., Pan H., Che F.Y. Peptidomics: identification and quantification of endogenous peptides in neuroendocrine tissues. Mass Spectrom Rev 2006, 25(2):327-344.
7. Dalsgaard C.J., Hultgardh-Nilsson A., Haegerstrand A., Nilsson J. Neuropeptides as growth factors. Possible roles in human diseases. Regul Pept 1989, 25(1):1-9.
8. Berberoglu Z., Yazici A.C., Bayraktar N., Demirag N.G. Rosiglitazone decreases fasting plasma peptide YY3-36 in type 2 diabetic women: a possible role in weight gain?. Acta Diabetol 2012, 49(Suppl. 1):S115-S122.
9. Svensson M., Skold K., Nilsson A., Falth M., Nydahl K., Svenningsson P., et al. Neuropeptidomics: MS applied to the discovery of novel peptides from the brain. Anal Chem 2007, 79(1):15-16. 18-21.
10. Che F.Y., Yan L., Li H., Mzhavia N., Devi L.A., Fricker L.D. Identification of peptides from brain and pituitary of Cpe(fat)/Cpe(fat) mice. Proc Natl Acad Sci U S A 2001, 98(17):9971-9976.
11. Dowell J.A., Heyden W.V., Li L. Rat neuropeptidomics by LC-MS/MS and MALDI-FTMS: enhanced dissection and extraction techniques coupled with 2D RP-RP HPLC. J Proteome Res 2006, 5(12):3368-3375.
12. Falth M., Skold K., Norrman M., Svensson M., Fenyo D., Andren P.E. SwePep, a database designed for endogenous peptides and mass spectrometry. Mol Cell Proteomics 2006, 5(6):998-1005.
13. Bora A., Annangudi S.P., Millet L.J., Rubakhin S.S., Forbes A.J., Kelleher N.L., et al. Neuropeptidomics of the supraoptic rat nucleus. J Proteome Res 2008, 7(11):4992-5003.
14. Evans S., Pamuklar Z., Rosko J., Mahaney P., Jiang N., Park C., et al. Gastric bypass surgery restores meal stimulation of the anorexigenic gut hormones glucagon-like peptide-1 and peptide YY independently of caloric restriction. Surg Endosc 2012, 26(4):1086-1094.
15. Lee J.E., Atkins N., Hatcher N.G., Zamdborg L., Gillette M.U., Sweedler J.V., et al. Endogenous peptide discovery of the rat circadian clock: a focused study of the suprachiasmatic nucleus by ultrahigh performance tandem mass spectrometry. Mol Cell Proteomics 2010, 9(2):285-297.
16. Fricker L.D. Analysis of mouse brain peptides using mass spectrometry-based peptidomics: implications for novel functions ranging from non-classical neuropeptides to microproteins. Mol Biosyst 2010, 6(8):1355-1365.
17. Katz L.B., Gambale J.J., Rothenberg P.L., Vanapalli S.R., Vaccaro N., Xi L., et al. Pharmacokinetics, pharmacodynamics, safety, and tolerability of JNJ-38431055, a novel GPR119 receptor agonist and potential antidiabetes agent, in healthy male subjects. Clin Pharmacol Ther 2011, 90(5):685-692.
18. Bradley W.D., Zwingelstein C., Rondinone C.M. The emerging role of the intestine in metabolic diseases. Arch Physiol Biochem 2011, 117(3):165-176.
19. Basso N., Capoccia D., Rizzello M., Abbatini F., Mariani P., Maglio C., et al. First-phase insulin secretion, insulin sensitivity, ghrelin, GLP-1, and PYY changes 72h after sleeve gastrectomy in obese diabetic patients: the gastric hypothesis. Surg Endosc 2011, 25(11):3540-3550.
20. Chen R., Jiang X., Conaway M.C., Mohtashemi I., Hui L., Viner R., et al. Mass spectral analysis of neuropeptide expression and distribution in the nervous system of the lobster Homarus americanus. J Proteome Res 2010, 9(2):818-832.
21. Che F.Y., Lim J., Pan H., Biswas R., Fricker L.D. Quantitative neuropeptidomics of microwave-irradiated mouse brain and pituitary. Mol Cell Proteomics 2005, 4(9):1391-1405.
22. Svensson M., Boren M., Skold K., Falth M., Sjogren B., Andersson M., et al. Heat stabilization of the tissue proteome: a new technology for improved proteomics. J Proteome Res 2009, 8(2):974-981.
23. Taylor S.W., Andon N.L., Bilakovics J.M., Lowe C., Hanley M.R., Pittner R., et al. Efficient high-throughput discovery of large peptidic hormones and biomarkers. J Proteome Res 2006, 5(7):1776-1784.
24. Frank A.M., Savitski M.M., Nielsen M.L., Zubarev R.A., Pevzner P.A. De novo peptide sequencing and identification with precision mass spectrometry. J Proteome Res 2007, 6(1):114-123.
25. Zougman A., Pilch B., Podtelejnikov A., Kiehntopf M., Schnabel C., Kumar C., et al. Integrated analysis of the cerebrospinal fluid peptidome and proteome. J Proteome Res 2008, 7(1):386-399.
26. Schmidt A., Gehlenborg N., Bodenmiller B., Mueller L.N., Campbell D., Mueller M., et al. An integrated, directed mass spectrometric approach for in-depth characterization of complex peptide mixtures. Mol Cell Proteomics 2008, 7(11):2138-2150.
27. Sze L., Purtell L., Jenkins A., Loughnan G., Smith E., Herzog H., et al. Effects of a single dose of exenatide on appetite, gut hormones, and glucose homeostasis in adults with Prader-Willi syndrome. J Clin Endocrinol Metab 2011, 96(8):E1314-E1319.
28. Olsen J.V., de Godoy L.M., Li G., Macek B., Mortensen P., Pesch R., et al. Parts per million mass accuracy on an Orbitrap mass spectrometer via lock mass injection into a C-trap. Mol Cell Proteomics 2005, 4(12):2010-2021.
29. Huml M., Kobr J., Siala K., Varvarovska J., Pomahacova R., Karlikova M., et al. Gut peptide hormones and pediatric type 1 diabetes mellitus. Physiol Res 2011, 60(4):647-658.
30. Hummon A.B., Richmond T.A., Verleyen P., Baggerman G., Huybrechts J., Ewing M.A., et al. From the genome to the proteome: uncovering peptides in the Apis brain. Science 2006, 314(5799):647-649.
31. Xie F., London S.E., Southey B.R., Annangudi S.P., Amare A., Rodriguez-Zas S.L., et al. The zebra finch neuropeptidome: prediction, detection and expression. BMC Biol 2010, 8:p28.
32. Cao J., Yang E.B., Su J.J., Li Y., Chow P. The tree shrews: adjuncts and alternatives to primates as models for biomedical research. J Med Primatol 2003, 32(3):123-130.
33. Martin R.D. Are tree shrews primates? Primate origins and evolution ed. Primate origins and evolution 1990, Chapman & Hall, London, UK.
34. Holmgren S., Jensen J. Evolution of vertebrate neuropeptides. Brain Res Bull 2001, 55(6):723-735.
35. Fink G., Harmar A.J. Neuropeptides: a methodology. IBRO handbook series. 1989, xv:345. Wiley, Chichester, England/New York.
36. Rutishauser J. Copeptin: diagnostic parameter, biomarker, or both?. Ther Umsch 2009, 66(11):731-734.
37. Merighi A. Neuropeptides: methods and protocols. 2011, Springer, New York.
38. Soloviev M. Peptidomics: methods and protocols. Springer protocols 2010, xiv:395. Humana Press, New York, NY.
39. Lipton M.S., Paša-Tolici L. Mass spectrometry of proteins and peptides: methods and protocols. Methods in molecular biology 2009, xiv:470. Humana, New York. 2nd ed.
40. Romanova E.V., Lee J.E., Kelleher N.L., Sweedler J.V., Gulley J.M. Mass spectrometry screening reveals peptides modulated differentially in the medial prefrontal cortex of rats with disparate initial sensitivity to cocaine. AAPS J 2010, 12(3):443-454.
41. Sweedler J.V., Li L., Rubakhin S.S., Alexeeva V., Dembrow N.C., Dowling O., et al. Identification and characterization of the feeding circuit-activating peptides, a novel neuropeptide family of aplysia. J Neurosci 2002, 22(17):7797-7808.
42. Falth M., Skold K., Svensson M., Nilsson A., Fenyo D., Andren P.E. Neuropeptidomics strategies for specific and sensitive identification of endogenous peptides. Mol Cell Proteomics 2007, 6(7):1188-1197.
43. Picotti P., Aebersold R. Selected reaction monitoring-based proteomics: workflows, potential, pitfalls and future directions. Nat Methods 2012, 9(6):555-566.
44. Romanova E.V., Dowd S.E., Sweedler J.V. Quantitation of endogenous peptides using mass spectrometry based methods. Curr Opin Chem Biol 2013, 17(5):801-808.
45. Kultima K., Nilsson A., Scholz B., Rossbach U.L., Falth M., Andren P.E. Development and evaluation of normalization methods for label-free relative quantification of endogenous peptides. Mol Cell Proteomics 2009, 8(10):2285-2295.
46. Che F.Y., Biswas R., Fricker L.D. Relative quantitation of peptides in wild-type and Cpe(fat/fat) mouse pituitary using stable isotopic tags and mass spectrometry. J Mass Spectrom 2005, 40(2):227-237.
47. Xiang F., Ye H., Chen R., Fu Q., Li L. N,N-dimethyl leucines as novel isobaric tandem mass tags for quantitative proteomics and peptidomics. Anal Chem 2010, 82(7):2817-2825.
48. Zhang X., Che F.Y., Berezniuk I., Sonmez K., Toll L., Fricker L.D. Peptidomics of Cpe(fat/fat) mouse brain regions: implications for neuropeptide processing. J Neurochem 2008, 107(6):1596-1613.
49. Fouillen L., Petruzziello F., Veit J., Bhattacharyya A., Kretz R., Rainer G., et al. Neuropeptide alterations in the tree shrew hypothalamus during volatile anesthesia. J Proteomics 2013, 80:311-319.
50. Romanova E.V., Lee J.E., Kelleher N.L., Sweedler J.V., Gulley J.M. Comparative peptidomics analysis of neural adaptations in rats repeatedly exposed to amphetamine. J Neurochem 2012, 123(2):276-287.
51. Arsenault J., Ferrari E., Niranjan D., Cuijpers S.A., Gu C., Vallis Y., et al. Stapling of the botulinum type A protease to growth factors and neuropeptides allows selective targeting of neuroendocrine cells. J Neurochem 2013, 126(2):223-233.